IMPACT-1 Study for People Suffering with PTSD

Posted on October 4th, 2024

The IMPACT-1 Study is clinical trial exploring the effect of an investigational, psychoactive oral medication for PTSD symptoms. People who have experienced a traumatic event and are now suffering symptoms of post-traumatic stress disorder (PTSD) can participate. The study is actively enrolling new participants and it is being conducted at select locations in the US, UK and Ireland. Click here to view a list of current study locations.

If you qualify for the IMPACT-1 Study, you can expect:

• Evaluations of your PTSD symptoms and overall health from a local physician.
• Study-related care at no cost and the potential to receive investigational oral medication.
• Compensation for travel expenses.
• The opportunity to help advance PTSD research, which may benefit other people with PTSD in the future.
• Privacy: All participant’s information will remain completely confidential.

For more information, click here to view the IMPACT-1 Study brochure, or visit impact1study.com.